Prostate Cancer is one of the leading causes of death in men, responsible for about 1 in every 44 deaths. But, it's one of the few cancers that is completely curable. Mark was 51 years old when diagnosed with prostate cancer in 2015. Now, almost a decade later he is online to tell his story of how he was diagnosed, and what other men should expect on their path to being cured of this disease. He talks about how he learned about his cancer, the surgery that saved his life, and how he manages ...
…
continue reading
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed. Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
…
continue reading
A urology podcast, focussing on all things prostate, kidney, bladder, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org
…
continue reading
1
Lessons from ACDC-RP Trial: Designing Neoadjuvant Therapy Trials for Prostatectomy
3:07
3:07
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:07
Oncotarget #published this #editorial on September 30, 2024, in Volume 15, entitled “Lessons from the ACDC-RP trial: Clinical trial design for radical prostatectomy neoadjuvant therapy trials” by Rashid K. Sayyid and Neil E. Fleshner from the Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Can…
…
continue reading
1
Molecular Chaperones: Guardians of Tumor Suppressor Stability
3:01
3:01
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:01
BUFFALO, NY- October 16, 2024 – A new #review was #published in Oncotarget's Volume 15 on October 1, 2024, entitled, “Molecular chaperones: Guardians of tumor suppressor stability and function.”As highlighted in the abstract of this paper, "tumor suppressor" describes a diverse set of genes typically involved in suppressing metastasis, but which ca…
…
continue reading
1
TP53 Mutated AML: Transplant or No Transplant
3:49
3:49
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:49
BUFFALO, NY- October 11, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on October 1, 2024, entitled, “Transplant or no transplant for TP53 mutated AML.”As highlighted in this editorial, TP53 mutations (mut) occur in 10–15% of acute myeloid leukemia (AML) cases, commonly associated with therapy-related AML (t-AML) and complex cyto…
…
continue reading
1
Targeting Stem Cell-like Traits: How miR-10b Inhibition Treats Metastatic Breast Cancer
6:01
6:01
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
6:01
While there have been significant improvements in breast cancer detection and treatment, the outlook for metastatic breast cancer remains bleak, with only a 30% five-year survival rate. This is largely due to existing therapies’ inability to effectively target the unique characteristics of metastatic cells. One key factor in metastasis is miR-10b, …
…
continue reading
1
Ten Years of ENZAMET | the gift that keeps on giving!
40:48
40:48
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
40:48
Today we celebrate one of our favourite clinical trials - ENZAMET! It is 10 years since ENZAMET opened and beyond its pivotal data establishing that adding enzalutamide to ADT improves survival for mHSPC patients, it continues to produce a very strong stream of high-quality findings that affect our practice today. ENZAMET also straddled an epochal …
…
continue reading
1
Zika Virus as a Treatment for Brain Cancer: A Systematic Review
3:28
3:28
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:28
BUFFALO, NY- October 9, 2024 – A new #review was #published in Oncotarget's Volume 15 on September 30, 2024, entitled, “Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review.”As highlighted in the introduction of this review, many studies have identified oncolytic viruses as a promising new class of t…
…
continue reading
1
All your GU Highlights from #ESMO24!
54:00
54:00
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
54:00
Ask anyone which big oncology meeting gave us the best GU oncology highlights this year and the answer is easy! ESMO24 in Barcelona! Jammed full of key papers and so many highlights, Declan and Renu bring you a great overview in this GU Cast Conference Highlights from ESMO24. Listen to discussions with investigators and key opinion leaders, intervi…
…
continue reading
1
GU Cast vs The Penis Project! With Melissa Hadley-Barrett
26:45
26:45
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
26:45
Penis Project is one of our favourite podcasts (and certainly popular with our patients), so we were delighted to welcome Host and Sexologist, Melissa Hadley-Barrett to join us for a chat. What is the Penis Project? Who is it for? (anyone with a penis, anyone who knows someone with a penis, or anyone who would like to have a penis apparently)! A cr…
…
continue reading
1
Spectacular live robotic surgery at #ERUS24 in Bordeaux
1:05:13
1:05:13
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:05:13
The world's longest running live robotic surgery meeting took place in Bordeaux last week and Declan and Renu were there to bring you all the highlights! The 21st Meeting of the EAU Robotic Urology Section (ERUS) was their biggest ever with more than 1000 delegates watching more than 40 live surgeries from the world's top robotic surgeons. And this…
…
continue reading
1
LuPSMA moves UpFront | first RCT data with Arun Azad and Michael Hofman
34:38
34:38
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
34:38
A big day at ESMO in Barcelona today as our friend and colleague A/Professor Arun Azad presents the results of the UpFront PSMA trial for the first time. The data were revealed in the main prostate cancer session at ESMO and simultaneously published in Lancet Oncology. UpFront PSMA is a randomised controlled trial comparing ADT and docetaxel, with …
…
continue reading
1
Salvage Robotic Radical Prostatectomy | 500 cases later with Paul Cathcart
30:52
30:52
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
30:52
More than 500 salvage radical prostatectomies!!! Yep it would be fair enough to describe Dr Paul Cathcart as being "experienced" in the most challenging scenario we face as prostate cancer surgeons. Surgery for cancer recurrence in the prostate following radiotherapy or various forms of ablative therapy is never easy, and can all too often lead to …
…
continue reading
Mark shares his experience with recurrent prostate cancer and his journey through radiation treatment. He discusses the use of ADT medication to reduce testosterone levels before radiation, the side effects of ADT, the process of radiation treatment, and the emotional journey of completing treatment. Mark also talks about the importance of early de…
…
continue reading
1
Three Big Waves in Testis Cancer | With Rob Hamilton and Ben Tran
26:14
26:14
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
26:14
Testis cancer! We don't talk enough about this on GU Cast. But we are making up for it today with a cracking overview of three hot topics in testis cancer a couple of world-leading testis cancer experts. We are joined by Rob Hamilton (Urologist, Princess Margaret Cancer Centre, Toronto), and Ben Tran (Medical Oncologist, Peter Mac, Melbourne) to di…
…
continue reading
1
Why you should go to Bali!! | #UAA24
7:10
7:10
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
7:10
As if any of us need an excuse to go to beautiful Bali! Well the Urological Association of Asia (UAA) Annual Meeting takes place there from 5-8th September 2024. Renu caught up with Dr Agus Rizal Hamid recently to hear what the UAA have in store for us! www.uaa2024.comעל ידי Professor Declan Murphy & Dr Renu Eapen
…
continue reading
1
Key Roles of MIF, DDT, and CD74 in Melanoma Prognosis and Therapy
4:02
4:02
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
4:02
Macrophage Migration Inhibitory Factor (MIF) and its homolog D-dopachrome Tautomerase (DDT) have been implicated as drivers of tumor progression in various cancers. Recent evidence suggests that MIF could be a therapeutic target in immune checkpoint inhibition (ICI) resistant melanomas; however, clinical evidence for MIF, and particularly for DDT, …
…
continue reading
1
miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer
2:41
2:41
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:41
BUFFALO, NY- August 28, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on August 26, 2024, entitled, “Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties.”As stated within the Abstract of the paper, despite advances in breast cancer screening and treatment, the prognosis for metastatic…
…
continue reading
1
PSA and Testosterone | Why low numbers matter
20:37
20:37
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
20:37
How often do you check PSA and testosterone in your patients on androgen deprivation therapy? Probably not often enough!! Declan caught up with friend of the podcast Professor Axel Merseburger at a conference recently to chat about this under-appreciated topic. Don't get too distracted by fancy scans and genomic testing; but do make sure you know a…
…
continue reading
1
Artificial Intelligence: Revolutionizing Precision Oncology
2:21
2:21
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:21
BUFFALO, NY- August 27, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on August 26, 2024, entitled, “Artificial intelligence: A transformative tool in precision oncology.”Artificial intelligence (AI) is revolutionizing society and healthcare, opening new possibilities for precision medicine. In oncology, immunotherapy (IO) has si…
…
continue reading
1
Genotype Matters: Tailored Screening for Germline CHEK2 Variants
2:45
2:45
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:45
BUFFALO, NY- August 26, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on July 10, 2024, entitled, “Genotype matters: Personalized screening recommendations for germline CHEK2 variants.”Recognized as a moderate-risk gene, CHEK2—responsible for encoding the CHK2 protein, which plays a crucial role in the repair of DNA double-strand…
…
continue reading
1
Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity
2:39
2:39
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:39
BUFFALO, NY- August 21, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on July 17, 2024, entitled, “Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity.”Two studies using CRISPR screens in cancer cells identified HLA-E as a critical negative regulator of NK cell interactions with cancer cells. Consiste…
…
continue reading
1
Role of the Gut Barrier in Colorectal Cancer Treatment
2:42
2:42
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:42
BUFFALO, NY- August 19, 2024 – A new #review was #published in Oncotarget's Volume 15 on August 14, 2024, entitled, “The gut barrier as a gatekeeper in colorectal cancer treatment.”Colorectal cancer (CRC) is highly prevalent and a major cause of cancer-related deaths worldwide. The primary curative treatment for CRC is surgical resection of the aff…
…
continue reading
1
Remembering Dr Brian Kelly
1:30:47
1:30:47
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:30:47
Today we dedicate our podcast to the memory of our colleague, Dr Brian Kelly (40), who passed away unexpectedly this week. We are devastated to lose Brian, who was a Consultant Urologist at Peter Mac and Eastern Health here in Melbourne, and one of our closest friends in the world. Here we replay the Memorial Session which we conducted at Peter Mac…
…
continue reading
1
Nanobody Inhibits Metastasis of Breast Tumor Cells to Lung in Mice
2:53
2:53
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:53
BUFFALO, NY- August 15, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on August 14, 2024, entitled, “A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice.”The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that functions to control the pH of intracellular …
…
continue reading
1
Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors
2:48
2:48
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:48
BUFFALO, NY- August 14, 2024 – A new #casereport was #published in Oncotarget's Volume 15 on July 17, 2024, entitled, “Rapid but nondurable response of a BRAF exon 15 double-mutated spindle cell sarcoma to a combination of BRAF and MEK inhibitors.”As noted in the introduction of the Abstract, the BRAF V600E substitution predicts a cancer's sensitiv…
…
continue reading
1
New Directions in Targeting the Multifaceted BRAF in Cancer
2:28
2:28
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:28
BUFFALO, NY- August 12, 2024 – A new research perspective was published in Oncotarget's Volume 15 on July 16, 2024, entitled, “Targeting the multifaceted BRAF in cancer: New directions.”In cancer patients, BRAF-targeting precision therapeutics are effective against Class I BRAF alterations (p.V600 hotspot mutations) in tumors such as melanoma, thyr…
…
continue reading
1
Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness
4:01
4:01
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
4:01
In this research paper, researchers demonstrate a promising new treatment option for refractory metastatic gastrointestinal cancers using a combination of two FDA-approved drugs.Researchers Jun Zhang, Lanlan Zhou, Shuai Zhao, and Wafik S. El-Deiry from Fox Chase Cancer Center and Brown University explore the potential of combining TAS102 (triflurid…
…
continue reading
1
Three big things in advanced/high risk kidney cancer | With Rana McKay and Lewis Au
38:20
38:20
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
38:20
We were very happy to have world-famous kidney cancer guru Dr Rana McKay in Australia this week to do some educational events and to visit us at Peter Mac. So of course we also invited her to the GU Cast studio to pick her brains on all things kidney cancer, along with Dr Lewis Au, GU Medical Oncologist at Peter Mac. We asked them to cover three ho…
…
continue reading
1
TCR CDR3s and Renalase-1 Linked to Increased Melanoma Survival
2:31
2:31
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:31
BUFFALO, NY- August 8, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on August 5, 2024, entitled, “Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival.”As mentioned in the Abstract of this study, overexpression of the secretory protein renalase-1 negati…
…
continue reading
1
Dealing with Runaway Metastatic Disease
1:59
1:59
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:59
BUFFALO, NY - August 7, 2024 – A new #editorial paper was #published in Oncotarget's Volume 15 on July 12, 2024, entitled, “How to deal with runaway metastatic disease?”In this new editorial, Justine Paris and Guilhem Bousquet from Université Paris Cité, Université Sorbonne Paris Nord, and APHP, Hôpital Avicenne, Oncologie médical, discussed how th…
…
continue reading
1
INT-1B3 miR-193a-3p Mimic Boosts T Cell Immunity and Induces Tumor Cell Death
2:34
2:34
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:34
BUFFALO, NY- August 5, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on July 12, 2024, entitled, “INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death.”In this study, resear…
…
continue reading
1
Sunshine and Science from #ANZUP24 on the Gold Coast
52:19
52:19
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
52:19
Renu and Declan escape winter in Melbourne to enjoy a few days of sunshine and science at the #ANZUP24 Annual Scientific Meeting on the Gold Coast. ANZUP is our fantastic GU Oncology co-operative trials group here in Australia and New Zealand and have an outstanding record in running clinical trials and supporting research and education in GU Oncol…
…
continue reading
1
The Prostate Cancer Olympics 2024! With Elena Castro and Arun Azad
44:13
44:13
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
44:13
To celebrate the Paris 2024 Olympics, we bring you this special Olympics-themed episode of GU Cast - our very own Prostate Cancer Olympics! Yes we We are joined in the GU Cast studio by Dr Elena Castro, GU Medical Oncologist at Hospital 12 de Octubre in Madrid, who happened to be passing through Melbourne. And by our own A/Professor Arun Azad, GU M…
…
continue reading
1
Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma
3:32
3:32
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:32
BUFFALO, NY- July 26, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on July 19, 2024, entitled, “Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.”Macrophage Migration Inhibitory Factor (MIF) and its homolog D-dopachrome Tautomerase (DDT) have been implicated as drivers of tumor progression across a va…
…
continue reading
1
Radical prostatectomy and the wave of new robots in China today
33:15
33:15
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
33:15
In the second of our special episodes focussing on GU Oncology in China, we are delighted to welcome back our GU Cast China Editor. Professor Yao Zhu, who has put together this cracking epsiode focussing on radical prostatectomy in China. We are joined by Professor Ming Liu (Beijing Hospital, Beijing) and Professor Jiahua Pan (Ren Ji Hospital, Shan…
…
continue reading
1
Novel Triple-Drug Combination to Fight Pancreatic Cancer
8:10
8:10
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
8:10
In the ever-evolving quest for effective cancer treatments, researchers are continuously exploring innovative combinatorial approaches that exploit the vulnerabilities of malignant cells. In a new study, researchers Benigno C. Valdez, Apostolia M. Tsimberidou, Bin Yuan, Yago Nieto, Mehmet A. Baysal, Abhijit Chakraborty, Clark R. Andersen, and Borje…
…
continue reading
1
Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis
2:54
2:54
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:54
BUFFALO, NY- July 24, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on July 22, 2024, entitled, “Prevalence and impact of the KIT M541L variant in patients with mastocytosis.”Activating mutations in KIT, particularly D816V, have been associated with mastocytosis. Additionally, expression of heterozygous KIT M541L has been pr…
…
continue reading
1
Oncotarget Welcomes New Editorial Board Members
1:40
1:40
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:40
BUFFALO, NY - July 22, 2024 – Oncotarget proudly welcomes new members to our esteemed Editorial Board, including our new Co-Editor-in-Chief, Dr. Wafik S. El-Deiry. Joining Dr. El-Deiry on Oncotarget’s Editorial Board are Dr. Trever Bivona, Dr. Phillip Buckhaults, Dr. Fred Bunz, Dr. Jonathan Chernoff, Dr. Stephen G. Chun, Dr. Nathan Dolloff, Dr. Pei…
…
continue reading
1
Efficacy of Pembrolizumab with sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC
3:21
3:21
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:21
BUFFALO, NY- July 22, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on July 10, 2024, entitled, “Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.”Patients with relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) after …
…
continue reading
1
DDX41’s Unique Contribution to Myeloid Leukemogenesis
2:35
2:35
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:35
BUFFALO, NY- July 19, 2024 – A new #editorial paper was #published in Oncotarget's Volume 15 on July 2, 2024, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.”In this new editorial, researcher Hirotaka Matsui from the National Cancer Center Hospital in Tokyo, Japan, and Kumamoto University discusses myeloid neoplasms. Until t…
…
continue reading
1
#109 - Surgery's Complete. Now What?
28:45
28:45
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
28:45
This conversation is about the recovery process after prostate surgery. The speaker shares his personal experience and provides tips and advice for surviving post-surgery. He discusses waking up after surgery, the presence of a catheter, the recovery room, hospital stay, diet, bowel movements, continence, and erectile function. He emphasizes the im…
…
continue reading
1
Using Early On-treatment ctDNA Measurements as Response Assessment in mCRPC
2:34
2:34
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:34
BUFFALO, NY- July 17, 2024 – A new #editorial paper was #published in Oncotarget's Volume 15 on July 2, 2024, entitled, “Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer.”In this new editorial, researchers S.H. Tolmeijer, E. Boerrigter, N.P. Van Erp, and Niven Mehr…
…
continue reading
1
We meet the Active Surveillor | Howard Wolinsky
36:08
36:08
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
36:08
There are patient advocates and there are patient advocates, and then there is Howard Wolinsky! We chat with the inimitable Howard, medical journalist and very long-time active surveillance patient, about his varied interests in low-risk prostate cancer and prostate cancer diagnostics. He runs a great substack called The Active Surveillor with a re…
…
continue reading
1
HER2-low and HER2-zero in Breast Cancer Between Prognosis, Prediction and Entity
2:41
2:41
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:41
BUFFALO, NY- July 16, 2024 – A new #editorial paper was #published in Oncotarget's Volume 15 on June 20, 2024, entitled, “HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.”In this new editorial, researchers Marcus Schmidt, Hans-Anton Lehr, and Katrin Almstedt from the University Medical Center of Johannes Gutenberg U…
…
continue reading
1
Comparison of FDG-PET/CT and CT for Treatment Evaluation of Patients With Unresectable Mesothelioma
4:12
4:12
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
4:12
BUFFALO, NY- July 15, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.”Malignant pleural mesothelio…
…
continue reading
1
AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging
5:51
5:51
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
5:51
Positron Emission Tomography (PET) combined with Computed Tomography (CT) is a powerful imaging modality used in oncology for diagnosis, staging, and treatment monitoring. However, one limitation of PET/CT is the need for accurate attenuation correction (AC) to account for tissue density variations. Traditionally, low-dose CT scans are used for AC,…
…
continue reading
1
Targeting ABC Transporters in PDAC – Past, Present, or Future?
3:00
3:00
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:00
BUFFALO, NY- July 10, 2024 – A new #editorial paper was #published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Targeting ABC transporters in PDAC – past, present, or future?”In this new editorial, Cecilia Bergonzini, Elisa Giovannetti and Erik H.J. Danen from Leiden University discuss targeting ABC transporters in pancreatic ductal carci…
…
continue reading
1
#108 - How to Eat, Train and Prepare for Prostate Cancer Treatment
36:05
36:05
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
36:05
This podcast episode provides tips and advice for individuals preparing for surgery or radiation for prostate cancer or recurrence of prostate cancer. The host, a prostate cancer survivor, shares his personal experience and the strategies he used to prepare his body for these procedures. The episode covers topics such as diet, exercise, Kegel exerc…
…
continue reading
1
#APCCC24 Conference Highlights | Part 2
1:06:10
1:06:10
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
1:06:10
Part 2 of our Conference Highlight specials from the Advanced Prostate Cancer Consensus Conference, held in April 2024 in Lugano. This is our very favourite prostate cancer meeting and we are thrilled to bring you these highlight podcasts. In this episode we chat with Elena Castro, Nick James, Anthony Joshua, Bertrand Tombal, Silke Gillessen, Aurel…
…
continue reading
1
Regorafenib Synergizes With TAS102 Against Multiple Gastrointestinal Cancers
3:25
3:25
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
3:25
BUFFALO, NY- July 8, 2024 – A new research paper was published in Oncotarget's Volume 15 on July 2, 2024, entitled, “Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status.”Single-agent TAS1…
…
continue reading
1
Editorial: Genomics Has More to Reveal
2:33
2:33
נגן מאוחר יותר
נגן מאוחר יותר
רשימות
לייק
אהבתי
2:33
BUFFALO, NY- July 2, 2024 – A new editorial paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Genomics has more to reveal.”In this new editorial, researchers Laurène Fenwarth and Nicolas Duployez from the University of Lille and CHU Lille discuss molecular and cytogenetic analyses that are now used to identify mutations and…
…
continue reading